Two Sigma Advisers’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Two Sigma Advisers’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-370,500	Closed	-$2.16M	–	2825
2022 Q4	$2.16M	Sell	370,500 -117,800	-24%	-$688K	0.01%	1198
2022 Q3	$3.27M	Buy	488,300 +340,700	+231%	+$2.28M	0.01%	941
2022 Q2	$621K	Buy	147,600 +82,000	+125%	+$345K	﹤0.01%	1828
2022 Q1	$221K	Sell	65,600 -29,800	-31%	-$100K	﹤0.01%	2352
2021 Q4	$301K	Buy	95,400 +45,900	+93%	+$145K	﹤0.01%	2142
2021 Q3	$162K	Buy	49,500 +3,200	+7%	+$10.5K	﹤0.01%	2283
2021 Q2	$195K	Sell	46,300 -33,700	-42%	-$142K	﹤0.01%	2276
2021 Q1	$399K	Sell	80,000 -13,200	-14%	-$65.8K	﹤0.01%	2104
2020 Q4	$1.18M	Sell	93,200 -8,000	-8%	-$101K	﹤0.01%	1486
2020 Q3	$994K	Sell	101,200 -22,192	-18%	-$218K	﹤0.01%	1500
2020 Q2	$1.23M	Buy	123,392 +492	+0.4%	+$4.9K	﹤0.01%	1475
2020 Q1	$1.09M	Buy	122,900 +8,100	+7%	+$71.6K	﹤0.01%	1437
2019 Q4	$1.06M	Buy	114,800 +6,000	+6%	+$55.3K	﹤0.01%	1551
2019 Q3	$640K	Buy	108,800 +4,400	+4%	+$25.9K	﹤0.01%	1616
2019 Q2	$1.25M	Buy	104,400 +44,800	+75%	+$538K	﹤0.01%	1416
2019 Q1	$719K	Sell	59,600 -8,800	-13%	-$106K	﹤0.01%	1649
2018 Q4	$858K	Sell	68,400 -4,700	-6%	-$59K	﹤0.01%	1556
2018 Q3	$1.09M	Buy	73,100 +4,200	+6%	+$62.3K	﹤0.01%	1476
2018 Q2	$1.16M	Buy	68,900 +25,000	+57%	+$421K	﹤0.01%	1551
2018 Q1	$1.01M	Sell	43,900 -13,938	-24%	-$319K	﹤0.01%	1542
2017 Q4	$1.5M	Buy	+57,838	New	+$1.5M	﹤0.01%	1379
2016 Q4	–	Sell	-11,600	Closed	-$117K	–	2485
2016 Q3	$117K	Sell	11,600 -6,100	-34%	-$61.5K	﹤0.01%	2119
2016 Q2	$199K	Buy	17,700 +1,300	+8%	+$14.6K	﹤0.01%	1862
2016 Q1	$224K	Buy	+16,400	New	+$224K	﹤0.01%	1791
2015 Q2	–	Sell	-27,400	Closed	-$415K	–	2122
2015 Q1	$415K	Buy	+27,400	New	+$415K	﹤0.01%	1438